Published in J Infect Dis on October 01, 1999
HIV-1 viral load assays for resource-limited settings. PLoS Med (2006) 3.30
Role of the laboratory in ensuring global access to ARV treatment for HIV-infected children: consensus statement on the performance of laboratory assays for early infant diagnosis. Open AIDS J (2008) 1.74
p24 Antigen detection assay modified with a booster step for diagnosis and monitoring of human immunodeficiency virus type 1 infection. J Clin Microbiol (2003) 1.64
Comparison of an assay using signal amplification of the heat-dissociated p24 antigen with the Roche Monitor human immunodeficiency virus RNA assay. J Clin Microbiol (2002) 1.43
Ultrasensitive human immunodeficiency virus type 1 p24 antigen assay modified for use on dried whole-blood spots as a reliable, affordable test for infant diagnosis. Clin Vaccine Immunol (2006) 1.34
Detection and quantification of human immunodeficiency virus type 1 p24 antigen in dried whole blood and plasma on filter paper stored under various conditions. J Clin Microbiol (2005) 1.32
Evaluation of an ultrasensitive p24 antigen assay as a potential alternative to human immunodeficiency virus type 1 RNA viral load assay in resource-limited settings. J Clin Microbiol (2005) 1.21
Evaluation of two commercially available, inexpensive alternative assays used for assessing viral load in a cohort of human immunodeficiency virus type 1 subtype C-infected patients from South Africa. J Clin Microbiol (2005) 1.19
Evaluation of the ultrasensitive human immunodeficiency virus type 1 (HIV-1) p24 antigen assay performed on dried blood spots for diagnosis of HIV-1 infection in infants. Clin Vaccine Immunol (2007) 1.17
Pediatric human immunodeficiency virus screening in an African district hospital. Clin Diagn Lab Immunol (2005) 1.11
Ultrasensitive p24 antigen assay for diagnosis of perinatal human immunodeficiency virus type 1 infection. J Clin Microbiol (2007) 1.06
Lack of longitudinal intrapatient correlation between p24 antigenemia and levels of human immunodeficiency virus (HIV) type 1 RNA in patients with chronic hiv infection during structured treatment interruptions. J Clin Microbiol (2004) 1.04
Potential of a simplified p24 assay for early diagnosis of infant human immunodeficiency virus type 1 infection in Haiti. J Clin Microbiol (2007) 1.01
Detection of HIV-1 p24 Gag in plasma by a nanoparticle-based bio-barcode-amplification method. Nanomedicine (Lond) (2008) 0.95
Diagnosis of human immunodeficiency virus type 1 infection in infants by use of dried blood spots and an ultrasensitive p24 antigen assay. J Clin Microbiol (2008) 0.93
Using a simplified human immunodeficiency virus type 1 p24 antigen assay to diagnose pediatric HIV-infection in Malawi. J Clin Virol (2010) 0.91
Diagnostic accuracy of ultrasensitive heat-denatured HIV-1 p24 antigen in non-B subtypes in Kampala, Uganda. Int J STD AIDS (2011) 0.83
Enhanced Sensitivity for Detection of HIV-1 p24 Antigen by a Novel Nuclease-Linked Fluorescence Oligonucleotide Assay. PLoS One (2015) 0.83
Increased Sensitivity of HIV-1 p24 ELISA Using a Photochemical Signal Amplification System. J Acquir Immune Defic Syndr (2015) 0.78
A signal-to-cutoff ratio in the Abbott architect HIV Ag/Ab Combo assay that predicts subsequent confirmation of HIV-1 infection in a low-prevalence setting. J Clin Microbiol (2015) 0.78
TaqMan real-time reverse transcription-PCR and JDVp26 antigen capture enzyme-linked immunosorbent assay to quantify Jembrana disease virus load during the acute phase of in vivo infection. J Clin Microbiol (2005) 0.75
Establishment and Comparison of Two Different Diagnostic Platforms for Detection of DENV1 NS1 Protein. Int J Mol Sci (2015) 0.75
Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. Science (1984) 11.30
Serological analysis of a subgroup of human T-lymphotropic retroviruses (HTLV-III) associated with AIDS. Science (1984) 5.43
Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome. Lancet (1984) 3.77
Antibodies to HTLV-III in Swiss patients with AIDS and pre-AIDS and in groups at risk for AIDS. N Engl J Med (1985) 2.95
Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex. N Engl J Med (1985) 2.20
Detectionof reverse transcriptase activity in live attenuated virus vaccines. Clin Diagn Virol (1996) 1.87
Ultrasensitive retrovirus detection by a reverse transcriptase assay based on product enhancement. Proc Natl Acad Sci U S A (1994) 1.84
A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes. Cell (1997) 1.80
Performance of five different assays for the quantification of viral load in persons infected with various subtypes of HIV-1. Swiss HIV Cohort Study. J Acquir Immune Defic Syndr (2000) 1.69
Sensitive detection and early prognostic significance of p24 antigen in heat-denatured plasma of human immunodeficiency virus type 1-infected infants. Swiss Neonatal HIV Study Group. J Infect Dis (1994) 1.69
Simple monitoring of antiretroviral therapy with a signal-amplification-boosted HIV-1 p24 antigen assay with heat-denatured plasma. AIDS (1997) 1.50
Toxoplasmosis during pregnancy and infancy. A new approach for Switzerland. Swiss Med Wkly (2008) 1.49
The structure of the sarcomeric M band: localization of defined domains of myomesin, M-protein, and the 250-kD carboxy-terminal region of titin by immunoelectron microscopy. J Cell Biol (1996) 1.49
Human immunodeficiency virus type 1 p24 concentration measured by boosted ELISA of heat-denatured plasma correlates with decline in CD4 cells, progression to AIDS, and survival: comparison with viral RNA measurement. J Infect Dis (2000) 1.41
False-positive HIV-1 virus cultures using whole blood. AIDS (1992) 1.40
Emergence of Acquired HIV-1 Drug Resistance Almost Stopped in Switzerland: A 15-Year Prospective Cohort Analysis. Clin Infect Dis (2016) 1.39
Rapid feline immunodeficiency virus provirus quantitation by polymerase chain reaction using the TaqMan fluorogenic real-time detection system. J Virol Methods (1999) 1.36
Antibodies against three purified proteins of the human type C retrovirus, human T-cell leukemia-lymphoma virus, in adult T-cell leukemia-lymphoma patients and healthy Blacks from the Caribbean. Cancer Res (1983) 1.30
Antiretroviral treatment monitoring with an improved HIV-1 p24 antigen test: an inexpensive alternative to tests for viral RNA. J Med Virol (2001) 1.28
Antigens on HTLV-infected cells recognized by leukemia and AIDS sera are related to HTLV viral glycoprotein. Science (1984) 1.21
Infection of rabbits with human immunodeficiency virus. Nature (1988) 1.19
A novel and innovative quantitative kinetic software for virological colorimetric assays. J Virol Methods (1998) 1.19
High frequency of non-B subtypes in newly diagnosed HIV-1 infections in Switzerland. J Acquir Immune Defic Syndr (1999) 1.17
Mapping of a myosin-binding domain and a regulatory phosphorylation site in M-protein, a structural protein of the sarcomeric M band. Mol Biol Cell (1998) 1.16
Quantitative and sensitive detection of immune-complexed and free HIV antigen after boiling of serum. J Virol Methods (1993) 1.14
The environment in the provincial plan of Cremona, Italy. Environ Manage (2001) 1.11
In vivo genetic variability of the human immunodeficiency virus type 2 V3 region. J Virol (1992) 1.11
Community-acquired pneumonia in children due to Mycoplasma pneumoniae: diagnostic performance of a seminested 16S rDNA-PCR. Diagn Microbiol Infect Dis (2001) 1.11
Reverse transcriptase activity in chicken embryo fibroblast culture supernatants is associated with particles containing endogenous avian retrovirus EAV-0 RNA. J Virol (1997) 1.11
Residual HIV-RNA levels persist for up to 2.5 years in peripheral blood mononuclear cells of patients on potent antiretroviral therapy. AIDS Res Hum Retroviruses (2000) 1.10
Mutation of ornithine transcarbamylase (H136R) in a girl with severe intermittent orotic aciduria but normal enzyme activity. J Inherit Metab Dis (1997) 1.08
Use of HIV-1 p24 as a sensitive, precise and inexpensive marker for infection, disease progression and treatment failure. Int J Antimicrob Agents (2000) 1.07
Interventions to prevent vertical transmission of HIV-1: effect on viral detection rate in early infant samples. AIDS (2000) 1.06
Sensitive and quantitative detection of PCR-amplified HIV-1 DNA products by an enzyme linked immunoassay following solution hybridization with two differently labelled oligonucleotide probes. Mol Cell Probes (1993) 1.05
Frequent detection of HIV- and IgG-specific IgM and IgA antibodies in HIV-positive cord-blood sera: fine analysis by western blot. AIDS (1989) 1.03
Detection on four continents of dengue fever cases related to an ongoing outbreak in Luanda, Angola, March to May 2013. Euro Surveill (2013) 1.02
Antiretroviral therapy during pregnancy and premature birth: analysis of Swiss data. HIV Med (2010) 1.00
Regulation of neighboring gene expression by the herpes simplex virus type 1 thymidine kinase gene. Virology (1996) 0.96
Detection of HIV-1 sequences in children using radioactive and colorimetric polymerase chain reactions. J Med Virol (1994) 0.93
[Intrauterine and postnatal transfer of high risk newborn infants. Swiss Society of Neonatology]. Schweiz Med Wochenschr (1998) 0.93
Epidemiology of vertically transmitted HIV-1 infection in Switzerland: results of a nationwide prospective study. Swiss Neonatal HIV Study Group. Eur J Pediatr (1992) 0.92
Visual development in preterm and full-term infants: a prospective masked study. Invest Ophthalmol Vis Sci (1999) 0.91
Urinary JCV-DNA testing during natalizumab treatment may increase accuracy of PML risk stratification. J Neuroimmune Pharmacol (2012) 0.91
Level of human immunodeficiency virus DNA in peripheral blood mononuclear cells correlates with efficacy of antiretroviral therapy. J Clin Microbiol (1999) 0.91
Molecular epidemiology of the nasal colonization by methicillin-susceptible Staphylococcus aureus in Swiss children. Clin Microbiol Infect (2010) 0.90
Evaluation of diagnostic tests for HIV infection in infants born to HIV-infected mothers in Switzerland. AIDS (1988) 0.90
Elective neck dissection versus observation in primary parotid carcinoma. Otolaryngol Head Neck Surg (2005) 0.89
Growth in human immunodeficiency virus type 1-infected children treated with protease inhibitors. Eur J Pediatr (2001) 0.89
Developmental and molecular aspects of nephroblastomas induced by avian myeloblastosis-associated virus 2-O. J Virol (1985) 0.89
Specificity of human immunodeficiency virus (LAV/HTLV-III)-reactive antibodies in African sera from southeastern Tanzania. Acta Trop (1986) 0.87
Mode of delivery and vertical transmission of HIV-1: a review of prospective studies. Perinatal AIDS Collaborative Transmission Studies. J Acquir Immune Defic Syndr (1994) 0.86
Cardiopulmonary bypass primes polymorphonuclear leukocytes. J Surg Res (1998) 0.86
Incident Hepatitis C Virus Infections in the Swiss HIV Cohort Study: Changes in Treatment Uptake and Outcomes Between 1991 and 2013. Open Forum Infect Dis (2015) 0.86
Demonstration of viral antigen p24 in circulating immune complexes of two patients with human T-cell leukaemia/lymphoma virus (HTLV) positive lymphoma. Lancet (1984) 0.85
Sensitive detection and quantification of particle-associated reverse transcriptase in plasma of HIV-1-infected individuals by the product-enhanced reverse transcriptase (PERT) assay. J Med Virol (1996) 0.85
Structure of the mouse arylsulfatase A gene and cDNA. Genomics (1994) 0.85
Swiss recommendations for the management of varicella zoster virus infections. Swiss Med Wkly (2007) 0.85
Obesity Trends and Body Mass Index Changes After Starting Antiretroviral Treatment: The Swiss HIV Cohort Study. Open Forum Infect Dis (2014) 0.85
Strong Impact of Smoking on Multimorbidity and Cardiovascular Risk Among Human Immunodeficiency Virus-Infected Individuals in Comparison With the General Population. Open Forum Infect Dis (2015) 0.84
Prevalence of etravirine mutations and impact on response to treatment in routine clinical care: the Swiss HIV Cohort Study (SHCS). HIV Med (2009) 0.84
Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort Study. HIV Med (2010) 0.84
Anti-HIV IgM antibody analysis during early manifestations of HIV infections. AIDS (1987) 0.84
Inhibition of replication of fresh HIV type 1 patient isolates by a polypurine tract-specific self-complementary oligodeoxynucleotide. AIDS Res Hum Retroviruses (1996) 0.84
A phase I/IIA clinical study with a chimeric mouse-human monoclonal antibody to the V3 loop of human immunodeficiency virus type 1 gp120. J Infect Dis (1994) 0.84
Effect of cold on muscle potentials and electrolytes. Metabolism (1968) 0.84
Codon 215 mutations in human immunodeficiency virus-infected pregnant women. Swiss Collaborative 'HIV and Pregnancy' Study. J Infect Dis (1999) 0.84
A case of Cunninghamella bertholettiae rhino-cerebral infection in a leukaemic patient and review of recent published studies. Mycopathologia (2008) 0.83
Quantification of in vitro retroviral replication using a one-tube real-time RT-PCR system incorporating direct RNA preparation. J Virol Methods (2001) 0.83
Antibodies against three purified structural proteins of the human type-C retrovirus, HTLV, in Japanese adult T-cell leukemia patients, healthy family members, and unrelated normals. Int J Cancer (1983) 0.83
Long-term responses to treatment including ritonavir or nelfinavir in HIV-1-infected children. Pediatric AIDS Group of Switzerland. Infection (2000) 0.83
Atypical leishmaniasis in an HIV-2-seropositive patient from Guinea-Bissau. AIDS (1991) 0.83